Ulcerative Colitis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Ad Com March 8 for Pfizer's Xeljanz for ulcerative colitis - Seeking Alpha



Ad Com March 8 for Pfizer's Xeljanz for ulcerative colitis 
Seeking Alpha
The FDA's Gastrointestinal Drugs Advisory Committee will meet on March 8 to discuss Pfizer's (NYSE:PFE) marketing application seeking approval for XELJANZ (tofacitinib) for adult patients with moderately-to-severely active ulcerative colitis (UC) who ...

 


Patients with Crohn's disease often misdiagnosed for ulcerative colitis - WNDU-TV



WNDU-TV
 
Patients with Crohn's disease often misdiagnosed for ulcerative colitis 
WNDU-TV
Crohn's disease is a chronic inflammatory bowel disease of the digestive or GI tract. It causes inflammation, which can lead to abdominal pain, severe diarrhea, weight loss and fatigue. It is often misdiagnosed for ulcerative colitis. Crohn's can ...
New Crohn's, colitis support group formed - The Independent Massillon Independent
Healthy Living: Stopping IBD - 9 & 10 News 9&10 News
Ulcerative Colitis Forecast in 12 Major Markets 2017-2027 ? MilTech MilTech

all 5 news articles » 


Phase 1 Results Support Development of TopiVert Therapy for Ulcerative Colitis - IBD News Today



Phase 1 Results Support Development of TopiVert Therapy for Ulcerative Colitis 
IBD News Today
Positive safety data from a Phase 1 trial supports TopiVert's continued development of TOP1288 to treat ulcerative colitis, the British pharma company announced. TOP1288 targets several important enzymes including P38, Src, Lck and Syk ? all of which ...

 


German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study - Labiotech.eu (blog)



Labiotech.eu (blog)
 
German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study 
Labiotech.eu (blog)
The FDA will allow Immunic Therapeutics to commence a Phase II clinical trial to test its oral investigational drug, IMU-838, for the treatment of ulcerative colitis. Immunic Therapeutics, which closed a ?31M Series A last September, specializes in the ...

 


FDA OKs Application for Immunic's UC Therapy, Green-lighting Phase 2 Trial - IBD News Today



FDA OKs Application for Immunic's UC Therapy, Green-lighting Phase 2 Trial 
IBD News Today
The U.S. Food and Drug Administration has cleared the way for Immunic Therapeutics to begin a Phase 2 trial testing IMU-838, its therapy candidate for ulcerative colitis. The FDA's approval of Immunic's investigational new drug (IND) application allows ...

 


Abivax's Ulcerative Colitis Therapy Wins Extension Trial Approval in ... - IBD News Today



Labiotech.eu (blog)
 
Abivax's Ulcerative Colitis Therapy Wins Extension Trial Approval in ... 
IBD News Today
Read about regulators in Belgium approving Abivax's request for an extension trial of its ulcerative colitis therapy ABX464.
TopiVert Paves the Way for a New Therapy for Ulcerative Colitis Labiotech.eu (blog)

all 2 news articles » 


Palatin to Start Clinical Trials of Ulcerative Colitis Therapy After FDA Sign-off - IBD News Today



Palatin to Start Clinical Trials of Ulcerative Colitis Therapy After FDA Sign-off 
IBD News Today
The U.S. Food and Drug Administration's decision to accept Palatin's Investigational New Drug application for the treatment opened the door to the trials. PL-8177 regulates a protein known as melanocortin receptor 1, which plays a role in inflammation ...

 


Protalix Therapy Eliminates Ulcerative Colitis in a Third of Patients in Phase 2 Trial - IBD News Today



Equities.com
 
Protalix Therapy Eliminates Ulcerative Colitis in a Third of Patients in Phase 2 Trial 
IBD News Today
Protalix BioTherapeutics' ulcerative colitis therapy OPRX-106 eradicated the disease in a third of the first 14 patients participating in a Phase 2 clinical trial. Fifty-seven percent of the patients responded to the treatment in some way, Protalix ...
Protalix BioTherapeutics Reports Positive Interim Data from Phase II Clinical Trial of OPRX-106 in Patients with ... GlobeNewswire (press release)
Biotech Analysis Central Pharma News: Protalix Phase 2 Success ... Seeking Alpha
Protalix BioTherapeutics Just Took a Big Step Towards UC Approval Equities.com
Healio  -FierceBiotech  -The Center for Biosimilars 
all 30 news articles » 


Explaining the Challenges of Pediatric Ulcerative Colitis - Rare Disease Report



Rare Disease Report
 
Explaining the Challenges of Pediatric Ulcerative Colitis 
Rare Disease Report
With 3 potential therapies for pediatric ulcerative colitis receiving Orphan Drug Designation from the U.S. FDA since August, Rare Disease Report requested to sit down with Doghramji to discuss the outlook for this patient population.

and more » 


Monica Potter clears up pregnancy rumor to reveal health issue - WKYC-TV



WKYC-TV
 
Monica Potter clears up pregnancy rumor to reveal health issue 
WKYC-TV
A post shared by Monica Potter (@monicapottergram) on Jan 18, 2018 at 6:09am PST. She used her post to stress the importance of getting checked regularly by your doctor. ?This is not meant to be a joke. This is something I take very seriously, and I ...
Fans Are Convinced Monica Potter Is Pregnant After Cryptic Baby Bump Pic, but She's Not! Closer Weekly

all 26 news articles »